Scientific interest in conjugated linoleic acid (CLA) started in 1987 when Michael Pariza's team of Wisconsin University observed its inhibitory effects on chemically induced skin tumors in mice. Numerous studies have since examined CLA's role in cancer, immune function, oxidative stress, atherosclerosis, lipid and fatty acids metabolism, bone formation and composition, obesity, and diabetes. Still it's not clear yet either through which mechanisms CLA produces its numerous metabolic effects.
We now know that CLA contents in cow milk fat can be enriched through dry fractionation, but this knowledge doesn't allow sufficient certainty to qualify this nutrient, as a functional food, capable of increasing well being and reducing the risk of disease.
EulitzK.YuraweczM.P.SehatN.FrischteJ.RoachJ.A.MossobaM.M.KramerJ.K.AdolfR.O.KuY., 1999. Preparation, separation, and confirmation of the eight geometrical cis/trans conjugated linoleic acid isomer 8,10 through 11, 13–18:2. Lipids34:873.
2.
BeluryM.2002. Dietary conjugated linoleic acid in health: Physiological effects and mechanisms of action. Ann. Rev. Nutr.22:505.
3.
BanniS.AngioniE.CasuV.MelisM.P.CartaG.CorongiuF.P.TomphsonH.IpC., 1999. Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid. Carcinogenesis20:1019.
4.
MulvihillB., 2001. Ruminant meat as a source of conjugated linoleic acid (CLA). Nutr. Bull.26:295.
5.
GriinariJ.M.BaumanD.E., 1999. Biosynthesis of conjugated linoleic acid and ist incorporation into meat and milk in ruminants. In Advances in Conjugated Linoleic Acid Research. AOCS PressChampaign IL., p. 180.
6.
FritscheJ.SteinhartH., 1998. Amounts of conjugated linoleic acid (CLA) in German foods and evaluation of daily intake. Z. Lebensm. Unters. Forsch.206:77.
7.
ZlatanosS.LaskaridisK.FeistC.SagredosA., 2002. CLA content and fatty acid composition of Greek Feta and hard cheeses. Food Chemistry78:471.
8.
Garcia-LopezS.EcheverriaE.TsuiI.BalchB., 1994. Changes in the content of conjugated linoleic acid (CLA) in processed cheese during processing. Food Res. Int.27:61.
9.
JiangJ.BjorkL.FondénR., 1997. Conjugated linoleic acid in sweedish dairy products with special reference to the manufacture of hard cheese. Intern. Dairy J. 7:863.
10.
GnadigS.ChambaJ.F.PerreardE.ChappazS.RickertR.SteinhartH.BerdauxO., 2002. Influence of cheese processing on conjugated linoleic acid content and CLA isomercomposition. In 17th International Conference of Nutrition, W. 04, p. 102.
11.
RihanenE.L.GriinariM.HolmaM.RinnekangasM.PuthoM., Conjugated linoleic acid enriched dairy products. In 17th International Conference of Nutrition, W.04, p. 110.
12.
RoberfroidM., 2001. Functional Foods: A challenge for the future of the 21st century. In 17th International Congress of Nutrition, keynote lecture. W. 04, p. 1
13.
SiskM.HausmanD.MartinR.AzainM., 2001. Dietary conjugated linoleic acid reduces adiposity in lean but not obese Zucker rats. J. Nutr.131:1668.
14.
SmedmanA.VessbyB., 2001. Conjugated linoleic acid supplementation in humans-metabolic effects. J. Nutr.36:773.
15.
Tsuboyama-KasaokaN.TakahashiM.TanemuraK.KimH.J.TangeT., 2000. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes49:1534.
16.
HouseknechtK.L.Vanden HeuvelJ.P.Moya-CamarenaS.Y.PortocarreroC.P.PeckL.W., 1998. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Bioph. Res. Commun.244:678.
17.
ChinS.F.LiuW.StorksonJ.M.HaY.L.ParizaM.W., 1992. Dietary sources of conjugated dienoic isomers of linoleic acid: A newly recognized class of anticarcinogens. J. Food Compos. Anal.5:185.
18.
ParkY.StorksonJ.M.AlbrightK.J.LiuW.ParizaM.W., 1999. Evidence that the trans-10 cis-12 isomer of conjugared linoleic acid induces body composition changes in mice. Lipids34:235.
19.
YamasakiM.ManshoK.MishimaH.KasaiM.SuganoM.TachibanaH.YamadaK., 1999. Dietary effect of conjugated linoleic acid on lipid levels in white adipose tissue of Sprague-Dawly rats. Biosci. Biotechnol. Biochem.63:1104.
20.
OnukiK.HaramizuS.OkiK.IshiharaK.TushikiT., 2001. A single oral administration of conjugated linoleic acid enhanced energy metabolism in mice. Lipids37:583.
21.
EvansM.ParizaM.ParkY.CurtisL.KueblerB.McIntoshM., 2000. Trans-1 Ocis-12 conjugated linoleic acid reduces triglycerides content while differentially affecting peroxisome proliferator activated receptor g2 and aP2 expression in 3T3-L1 preadipocytes. Lipids36:1223.
22.
ParkY.AlbrightK.J.LiuW.CookM.E.ParizaM.W., 1995. Dietary conjugated linoleic acid reduces body fat content and isomers of CLA are incorporated into phospholipid fraction. IFT Annual MeetingA64:10.
23.
BenitoP.NelsonG.KelleyD.BartoliniG.SchmidtP.SimonV., 2001Effect of conjugated linoleic acid on platelet function, platelet fatty acid composition and blood coagulation in humans. Lipids36:221.
24.
BlanksonH.StakkestadJ.A.FagertunH.ThomE.WadsteinJ.GudmundsenO., 2000. Conjugated linoleic acid reduces body fat in overweight and obese humans. J. Nutr.130:2943.
25.
MedinaE.A.HornW.F.KeimN.L.HavelP.J.BenitoP.KelleyD.S.NelsonG.J.EricksonK.L., 2000. Conjugated linoleic acid supplementation in humans: Effects on circulating leptin concentration and appetite. Lipids35:783.
26.
ZambellK.L.KeimN.L.VanLoanM.D.GaleB.BenitoP.KelleyD.S.NelsonG.J., 2000. Conjugated linoleic acid supplementation in humans: Effects on body composition and energy expenditure. Lipids35:777.
27.
EvansE.M.BrownJ.M.McIntoshM.K., 2002. Isomer-specific effects of conjugated linoleic acid on adiposity and lipid metabolism. J. Nutr. Biochem.13:508.
28.
MougiosV.MatsakasA.PetridouA.RingS.SagredosA.MelissopoulouA.TsigilisN.NikolaidisM., 2001. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J. Nutr. Biochem.12:585.
29.
BrownJ.HalversonY.D.Lea-CurrieR.GeigermanC.McIntoshM., 2001. Trans 10, cis 12, but not cis 9, trans11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue. J. Nutr.131:2316.
30.
RiserusU.ParnerK.BrismarK.VessbyB., 2002. Treatment with dietary trans10 cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care25:1516.
31.
RiserusU.BerglundL.VessbyB., 2001. Conjugated linoleic acid reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: A randomised controlled trial. Int. J. Obes. Relat. Metab. Disord.25:1129.
32.
VessbyB.2000. Dietary fat and insulin action in humans. Br. J. Nutr.83:91.
33.
MedinaE.A.HornW.F.KeimN.L.HavelP.J.BenitoP.KelleyD.S.NelsonG.J.EricksonK.L., 2000. Conjugated linoleic acid supplementation in humans: Effects on circulating leptin concentrations and appetite. Lipids35:783.
34.
DiplockA.T.AggettP.J.AshwellM.BornetF.FernE.B.RoberfroidM. B., 1999. Scientific Concepts of Functional Foods in Europe: Consensus Document. Br. J. Nutr.81:56.
35.
BodenG.LebedB.SchatzM.HomkoC.LemieuxS., 2001. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes50:1612.
36.
GrecoA.MingroneG.GiancateriniA.MancoM.MorroniM.CintiS.GranzotM.VettorR.CalastraS.FerraniniE., 2002. Insulin resistance in morbid obesity: Reversal with intamyocellular fat deposition. Diabetes51:144.
37.
AlexandrakisM.G.KyriakouD.S.SeretakisD.BoucherW.LetourneauR.KempurajD.TheoharidesT.C., 2003. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (Hmc-1). Int. J. Immunopathol. Pharmacol.16:43
38.
PanarelliP.Viola-MagniM.P.AlbiE., 2002. Antiphosphatidylinositol antibody in deep venous thrombosis patients. Int. J. Immunopathol. Pharmacol.16:61.
39.
ChiappiniE.PeruzziM.GalliL.CalabriG.de MartirioM., 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with anticonvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol.15:239.
40.
HuangM.BerryJ.KandereK.LytinasM.KaralisK.TheoharidesT.C., 2002. Mast cell deficient W/Wv mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol.15:249.
41.
LosaJ.E.Perez-ArellanoJ.L., 2002. Anti-inflammatory effect of cyclosporin-A (CsA). Int. J. Immunopathol. Pharmacol.15 (S):7.
42.
TheoharidesT.C.AlexandrakisM.KempurajD.LytinasM., 2001. Anti-inflammatory actions of Flavonoids and structural requirements for new design. Int. J. Immunopathol. Pharmacol.14:119.
43.
ConfortiA.LussignoliS.BertaniS.OrtolaniR.CuzzolinL.BenoniG.BellaviteP., 2001. Cytokine and nitric oxide levels in a rat model of immunologic protection from adjuvant-induced arthritis. Int. J. Immunopathol. Pharmacol.14:153.
44.
ContiP.KempurajD.TheoharidesT.C., 2001. Mechanism by which IL-16 generated by mast cells mediates allergic inflammation. Int. J. Immunopathol. Pharmacol.14:1.
45.
AntusB.ExtonM.S.RosivallL., 2001. Angiotensin II: A regulator of inflammation during renal disease?Int. J. Immunopathol. Pharmacol.14:25.
